Deborah Lockwood is a Cardiology physician affiliated with University of Oklahoma Health Sciences Center. OpenAlex indexes 29 publications with 1,597 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 NE 10th St
Oupb 2500
Oklahoma City, OK 731045417
Telephone
405-271-7001Registry record last updated 10 Mar 2011.
Clinical trials
- Dual Versus Single Shock for Cardioversion of Atrial Fibrillation
Sponsor: University of Oklahoma
- Ablation of Inappropriate Sinus Tachycardia
Sponsor: University of Oklahoma
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Impulse Dynamics (USA) Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
69.9%Beta blocker15.1%Metoprolol Succinate64%Metoprolol Tartrate20%Carvedilol16%Part D<11 patientsStatin11.2%Atorvastatin Calcium100%Part D≥22 patients+ 6 more classes in this area
Blood & clotting
30.1%Factor Xa inhibitor23.2%Eliquis91%Xarelto9%Part D<11 patientsVitamin K antagonist4.6%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Systematic Evaluation of High-Resolution Activation Mapping to Identify Residual Endocardial and Epicardial Conduction Across the Mitral Isthmus
JACC. Clinical electrophysiology
2021 - 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions : a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI)
EP Europace
2019 - TRANSESOPHAGEAL ATRIAL PACING FOR TERMINATION OF ATRIAL TACHYCARDIA DURING PREGNANCY
Journal of the American College of Cardiology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Ira Targoff, MD
University of Oklahoma Health Sciences Center
Harold Burkhart, MD
University of Oklahoma Health Sciences Center
Steven Chernausek, MD
University of Oklahoma Health Sciences Center
Udho Thadani, MD
University of Oklahoma Health Sciences Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”